Story Navigation
-
DiscoveryFuture of HealthcareInnovationBiological battle of the bulge
John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.
Discovery -
From Our LabsNovartis Institutes for BioMedical Research10 big questions to dissect science papers
Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.
From Our Labs -
Patient PerspectivesChronic IllnessLiving With DiseaseNovartis Institutes for BioMedical ResearchRare DiseasesClinical TrialsNo longer living in fear
This moving personal story about the challenges of living with a rare disease is written by Rocco Falchetto, a biochemist and director of analytical sciences and imaging at the Novartis Institutes for BioMedical Research (NIBR).
Patient Perspectives -
From Our LabsDigitalEmerging TechnologyInnovationMedicine Safety3-D printing: Scientists reinvent research tools
The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.
From Our Labs -
Access to HealthcareAccess to HealthcareNovartis AccessDealing with the spread of chronic disease in Africa
Over the next 15 years chronic disease like cancer and heart disease will become major killers in Sub-Saharan Africa. A new report from the Economist Intelligence Unit explains why.
Access to Healthcare -
DiscoveryNovartis Institutes for BioMedical ResearchRare DiseasesClinical ResearchCareersBiomedical JobsGene TestingGenetic DiseaseNovartis researches SMA’s genetic roots
Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
Discovery -
Access to HealthcareDisease EradicationGlobal Health PartnershipsMalariaNovartis Social BusinessPatient EducationTropical DiseasesNew drugs could offer hope for malaria patients
In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.
Access to Healthcare -
DiscoveryNovartis Institutes for BioMedical ResearchNovartis scientists target resistance threat in malaria
Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.
Discovery -
DiscoveryNovartis Institutes for BioMedical ResearchMutant protein spreads through a neural circuit in Huntington’s Disease
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
Discovery -
Patient PerspectivesFuture of HealthcareMedical InnovationsNeurodegenerative DiseaseLongevity with vitality: Japanese elders provide examples for healthy aging
Ogimi in Okinawa, Japan has the highest percentage of centenarians in the world, making it a curiosity for those eager to learn more about the secrets of aging.
Patient Perspectives -
DiscoveryNovartis Institutes for BioMedical ResearchTargeted TherapyCancer cocktails come of age
Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.
Discovery -
CancerFuture of HealthcareInnovationCombination therapies: Seeking to block cancer’s pathways to growth
Talk to any cancer researcher or doctor today and what you hear is wonder and hope.
Pagination
- ‹ Previous page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- › Next page